APOTHEEK DELANG - GOOSSENS financials
A multi-period view of the public annual-account figures reported for APOTHEEK DELANG - GOOSSENS, with comparable measures and links to available source documents.
Company overviewRegistry number
0448489990
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for APOTHEEK DELANG - GOOSSENS
2025 versus 2024
- Operating line
- €196,695
- EBITDA
- €85,237
- Total assets
- €408,318
- Equity
- €125,260
-10%
-21.9%
+13.2%
0%
EBITDA margin +43.3% · Equity ratio +30.7%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €196,695 | €85,237 | €408,318 | €125,260 | - |
| 202431 Dec 2024 | €218,544 | €109,205 | €360,612 | €125,260 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.